OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
2263
Results
Show all
Save search
Copy query
Show results for
Unknown
(2204)
Transcriptomics
(29)
Proteomics
(21)
Genomics
(5)
Models
(2)
Metabolomics
(2)
Organisms
Homo sapiens
(18)
Andropogon gerardi
(12)
Bacteria
(12)
Bartonella quintana JK 31
(12)
Canis lupus familiaris
(12)
Cnidaria
(12)
Ensifer adhaerens
(12)
Human alphaherpesvirus 1 strain 17
(12)
Human alphaherpesvirus 1 strain KOS
(12)
Human betaherpesvirus 5
(12)
Human herpesvirus 2 strain 186
(12)
Mesocricetus auratus
(12)
Miscanthus x giganteus
(12)
Mus musculus
(12)
Panicum virgatum
(12)
Platyhelminthes
(12)
Pseudomonas aeruginosa PA103
(12)
Rabies virus Nishigahara RCEH
(12)
Mus musculus
(8)
Rattus norvegicus
(6)
Bombyx mori
(2)
Sus scrofa
(2)
Oryctolagus cuniculus
(1)
Cavia porcellus
(1)
Macaca fascicularis
(1)
Oryza sativa
(1)
Drosophila melanogaster
(1)
Arabidopsis thaliana
(1)
Gallus gallus
(1)
cellular organisms
(1)
Repository
biostudies-arrayexpress
(29)
pride
(12)
jPOST
(7)
EGA
(5)
BioModels
(2)
MassIVE
(2)
MetaboLights
(2)
Tissue
Brain
(1)
Bronchoalveolar lavage
(1)
Epithelial cell
(1)
Heart
(1)
Lung
(1)
Tissue
(1)
Disease
Breast cancer
(1)
Pulmonary fibrosis
(1)
Trypanosomiasis
(1)
Technology Type
Mass Spectrometry
(12)
Affinity purification coupled with mass spectrometry proteomics
(3)
Bottom-up proteomics
(3)
Shotgun proteomics
(3)
Data-dependent acquisition
(2)
SWATH MS
(2)
NMR spectroscopy assay
(1)
NMR spectroscopy
(1)
Mass spectrometry
(1)
Mass spectrometry assay
(1)
Gel-based experiment
(1)
Instrument Platform
Agilent High resolution C scanner
(4)
Nuclear Magnetic Resonance (NMR) -
(2)
Liquid Chromatography MS - negative - reverse phase
(2)
Affymetrix Gene Titan
(1)
Gene Titan
(1)
Illumina NovaSeq 6000
(1)
Q Exactive
(1)
QExactive LCMS
(1)
Liquid Chromatography MS - alternating - reverse phase
(1)
Liquid Chromatography MS - positive - reverse phase
(1)
Liquid Chromatography MS - positive - hilic
(1)
Publication Date
2012
(6)
2016
(5)
2013
(5)
2011
(5)
2025
(5)
2015
(4)
2024
(4)
2023
(3)
2009
(3)
2026
(3)
2005
(2)
2021
(2)
2018
(2)
2014
(1)
2010
(1)
2008
(1)
2017
(1)
2022
(1)
CHEBI ID
CHEBI:17790
(1)
CHEBI:22652
(1)
CHEBI:16016
(1)
CHEBI:30751
(1)
CHEBI:16236
(1)
CHEBI:17824
(1)
CHEBI:16135
(1)
CHEBI:15344
(1)
CHEBI:17172
(1)
CHEBI:17748
(1)
CHEBI:27266
(1)
CHEBI:15428
(1)
CHEBI:16856
(1)
CHEBI:22660
(1)
CHEBI:16449
(1)
CHEBI:25017
(1)
CHEBI:24898
(1)
CHEBI:15940
(1)
CHEBI:22653
(1)
CHEBI:16040
(1)
CHEBI:16811
(1)
CHEBI:27570
(1)
CHEBI:26986
(1)
CHEBI:29016
(1)
CHEBI:33508
(1)
CHEBI:28300
(1)
CHEBI:15741
(1)
CHEBI:25094
(1)
CHEBI:17822
(1)
CHEBI:26271
(1)
Metabolite Name
2-Octenoylcarnitine CAR(8:1)
(1)
IsPrivate
False
(2)
Modelling Approach
Ordinary differential equation model
(2)
Study type
Transcription profiling by array
(24)
Animal - One-color microarray
(3)
RNA-seq of coding RNA from single cells
(1)
RNA-seq of non coding RNA
(1)
Release Date
2022
(271)
2025
(265)
2021
(258)
2023
(205)
2024
(202)
2020
(198)
2019
(141)
2018
(120)
2017
(109)
2016
(84)
2015
(74)
2014
(58)
2013
(43)
2012
(42)
2026
(33)
2011
(28)
2010
(27)
2008
(19)
2009
(11)
2007
(10)
2006
(8)
2004
(7)
2001
(6)
1999
(4)
2005
(3)
2003
(3)
2000
(2)
2002
(1)
1997
(1)
Lab affiliation
Biochemistry and Molecular Biology, Michael Smith Laboratories, University of British Columbia, Canada
(1)
Calpain Project Department of Advanced Science for Biomolecules Igakuken (Tokyo Metropolitan Institute of Medical Science) 2-1-6 Kamikitazawa, Setagaya-ku Tokyo 156-8506, Japan
(1)
Department of Cellular and Molecular Pharmacology, University of California San Francisco
(1)
Department of Physiology,Juntendo University Graduate School of Medicine
(1)
Department of Systems Pharmacology, Graduate School of Medicine, the University of Tokyo, Japan
(1)
Division of Infection Medicine, BMC Faculty of Medicine Lund University Lund, Sweden
(1)
Graduate school of Biomedical and Health Sciences, Hiroshima University
(1)
Principle Investigator
(1)
Professor of Cell Biology and Parasitology, FRSB Biological Chemistry and Drug Discovery Wellcome Centre for Anti-Infectives Research (WCAIR) School of Life Sciences University of Dundee MSI/WTB/JBC Complex Dow Street DUNDEE DD1 5EH, UK +44 (0)751-550-7880 mfield@mac.com
(1)
Proteome Research (AG Stühler) Heinrich Heine University Düsseldorf Universitätsstraße 1 40225 Düsseldorf Germany
(1)
SMBP
(1)
University of California San Francisco
(1)
Previous
page
1 / 227
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
227
Next
page
Sort
by:
Relevance
Page size
10
Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial.
Not available
S-EPMC4715857
|
biostudies-literature
Cite
Antiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis.
Not available
S-EPMC5477094
|
biostudies-literature
Cite
Discovery of ONO-2920632 (VU6011887): A Highly Selective and CNS Penetrant TREK-2 (TWIK-Related K+ Channel 2) Preferring Activator <i>In Vivo</i> Tool Compound.
Not available
S-EPMC11887051
|
biostudies-literature
Cite
First-in-human study of ONO-4578, an antagonist of prostaglandin E
2
receptor 4, alone and with nivolumab in solid tumors.
Not available
S-EPMC9807514
|
biostudies-literature
Cite
Randomised clinical trial: exploratory phase 2 study of ONO-2952 in diarrhoea-predominant irritable bowel syndrome.
Not available
S-EPMC5157770
|
biostudies-literature
Cite
ONO-4578 Plus Nivolumab in Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer.
Not available
S-EPMC12400061
|
biostudies-literature
Cite
Efficacy, Safety, and Tolerability of ONO-4474, an Orally Available Pan-Tropomyosin Receptor Kinase Inhibitor, in Japanese Patients With Moderate to Severe Osteoarthritis of the Knee: A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Comparative Study.
Not available
S-EPMC6973102
|
biostudies-literature
Cite
Optimization of Selective and CNS Penetrant Alkyne-Based TREK Inhibitors: The Discovery and Characterization of ONO-9517601 (VU6022856) and ONO-7927846 (VU6024391).
Not available
S-EPMC12621189
|
biostudies-literature
Cite
Evaluation of the effectiveness and safety of ONO-2910 for the treatment of diabetic polyneuropathy: An early Phase IIa, multicenter, randomized, placebo-controlled, double-blind study in Japanese patients.
Not available
S-EPMC12862990
|
biostudies-literature
Cite
Three-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: Pooled analysis of ONO-4538-05 and ONO-4538-06 studies.
Not available
S-EPMC6718542
|
biostudies-literature
Cite
Previous
page
1 / 227
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
227
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
